Septectomy and Septal Dermoplasty for the Treatment of Severe Transfusion-Dependent Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia and Septal Perforation
Lesnik GT, Ross DA, Henderson KJ, Joe JK, Leder SB, White RI. Septectomy and Septal Dermoplasty for the Treatment of Severe Transfusion-Dependent Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia and Septal Perforation. American Journal Of Rhinology And Allergy 2007, 21: 312-315. PMID: 17621815, DOI: 10.2500/ajr.2007.21.3017.Peer-Reviewed Original ResearchMeSH KeywordsEpistaxisHemoglobinsHumansNasal SeptumQuality of LifeRetrospective StudiesTelangiectasia, Hereditary HemorrhagicTransfusion ReactionConceptsHereditary hemorrhagic telangiectasiaSeptal dermoplastySeptal perforationQuality of lifeTransfusion requirementsHHT patientsHemorrhagic telangiectasiaMainstay of treatmentCentral nervous systemAutosomal dominant disorderMonopolar cauterizationGraft uptakeCommon manifestationMucocutaneous tissuesSubjective improvementEffective treatmentEpistaxisVisceral organsPatientsSeptectomyNervous systemAbnormal angiogenesisPatient resultsTelangiectasia formationCombined procedure